Medical Device Network on MSN
Helio Genomics and LiverRight team up for early detection of liver cancer
LiverTrace is designed for adults considered at risk for liver cancer, including those with previous liver conditions.
Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced the launch ...
A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled “SAMP ...
Helio Genomics ("Helio" or "the Company"), an AI-driven techbio company specializing in diagnostics technology for cancer ...
CNW/ - Syantra, Inc., a biotechnology company revolutionizing cancer detection, is announcing Scottsdale, Arizona based ...
The test, developed by Astrin Biosciences, utilizes deep proteomic profiling and a machine learning classifier to identify ...
The field of cancer immunology has experienced remarkable advancements in diagnostic capabilities, largely due to the integration of multispectral and hyperspectral imaging technologies. These imaging ...
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
The tool SAMP-Score has already screened 10,000 compounds and found one that safely forces stubborn, treatment-resistant ...
Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果